Literature DB >> 1312479

Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.

A M van Loon1, J T van der Logt, F W Heessen, M C Heeren, J Zoll.   

Abstract

Antibody-capture enzyme-linked immunosorbent assays (AC-ELISA) which use enzyme-labelled antigen were developed for detection of varicella-zoster virus-(VZV) specific IgM, IgA and IgG antibody in patients with varicella or herpes zoster and in sera from healthy individuals. All 18 patients with varicella developed a VZV-IgM and a VZV-IgG response, 17 also a VZV-IgA response. In contrast, all 19 patients with herpes zoster were shown to be positive for VZV-IgA whereas only 13 of these reacted positively for VZV-IgM. A VZV-IgM response was detected in only two sera from 100 healthy individuals and an IgA response in only one. The presence of virus-specific IgA and IgG in the cerebrospinal fluid as determined by AC-ELISA was a useful indicator of VZV infection of the central nervous system. By AC-ELISA, VZV-IgG was detected predominantly in sera from patients with acute or recent VZV infection. Only 14 sera from 100 healthy individuals were positive for VZV-IgG by AC-ELISA, whereas all were positive by an indirect ELISA. These results indicate that AC-ELISA's may be useful assays for determination for acute or recurrent VZV infection, but are not suitable for determination of past infection with this virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312479      PMCID: PMC2272196          DOI: 10.1017/s095026880004961x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster).

Authors:  N J Schmidt; A M Arvin
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

2.  Specific immunoglobulin responses after varicella and herpes zoster.

Authors:  J E Cradock-Watson; M K Ridehalgh; M S Bourne
Journal:  J Hyg (Lond)       Date:  1979-04

3.  Detection of specific IgM in varicella and herpes zoster by antibody-capture radioimmunoassay.

Authors:  H O Kangro; A Ward; S Argent; R B Heath; J E Cradock-Watson; M K Ridehalgh
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

4.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

5.  IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.

Authors:  A A Gershon; S P Steinberg; W Borkowsky; D Lennette; E Lennette
Journal:  Pediatr Infect Dis       Date:  1982 May-Jun

6.  Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.

Authors:  M Hacham; S Leventon-Kriss; I Sarov
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

7.  Detection of specific IgA antibodies in serum of patients with varicella and zoster infections.

Authors:  E Levy; I Sarov
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

8.  Immunologic evidence of reinfection with varicella-zoster virus.

Authors:  A M Arvin; C M Koropchak; A E Wittek
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

9.  Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus.

Authors:  A M van Loon; F W Heessen; J T van der Logt; J van der Veen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

10.  Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.

Authors:  A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

View more
  6 in total

1.  Clinical diagnosis of herpes zoster in family practice.

Authors:  Wim Opstelten; Anton M van Loon; Margje Schuller; Albert J M van Wijck; Gerrit A van Essen; Karel G M Moons; Theo J M Verheij
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  A Case of Associated Laryngeal Paralysis Caused by Varicella Zoster Virus without Eruption.

Authors:  Keishi Fujiwara; Yasushi Furuta; Satoshi Fukuda
Journal:  Case Rep Med       Date:  2014-03-12

4.  The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster.

Authors:  Seong-Won Min; Yung Suk Kim; Francis Sahngun Nahm; Da Hye Yoo; Eunjoo Choi; Pyung-Bok Lee; Hyunjung Choo; Zee-Yong Park; Catherine Seonghee Yang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system.

Authors:  Michele Souza Bastos; Jordana Grazziela Coelho-Dos-Reis; Danielle Alves Gomes Zauli; Felipe Gomes Naveca; Rossicleia Lins Monte; João Paulo Pimentel; Valéria Munique Kramer Macário; Natália Lessa da Silva; Vanessa Peruhype-Magalhães; Marcelo Antônio Pascoal-Xavier; Allyson Guimaraes; Andréa Teixeira Carvalho; Adriana Malheiro; Olindo Assis Martins-Filho; Maria Paula Gomes Mourão
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

6.  Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.

Authors:  Arnaud John Kombe Kombe; Jiajia Xie; Ayesha Zahid; Huan Ma; Guangtao Xu; Yiyu Deng; Fleury Augustin Nsole Biteghe; Ahmed Mohammed; Zhao Dan; Yunru Yang; Chen Feng; Weihong Zeng; Ruixue Chang; Keyuan Zhu; Siping Zhang; Tengchuan Jin
Journal:  Pathogens       Date:  2022-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.